Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Journal of Child and Adolescent Psychopharmacology
|
January 17, 2018
Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA
Xiuqing Zhu, Jinqing Hu, Bin Sun, et al.
Drug Design, Development and Therapy
|
September 22, 2021
Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level
Shanqing Huang, Lu Li, Zhanzhang Wang, et al.
Therapeutic Drug Monitoring
|
December 13, 2024
Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations
Ye Yang, Zhanzhang Wang, Tao Xiao, et al.
Drug Design, Development and Therapy
|
August 11, 2021
What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly
Tao Xiao, Zhanzhang Wang, Guanlie Li, et al.
Human Psychopharmacology
|
November 20, 2023
Factors influencing concentrations of risperidone and 9-hydroxyrisperidone in psychiatric outpatients taking immediate-release formulations of risperidone
Zhihao Guo, Chunxiu Chen, Shuhua Deng, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 24, 2016
Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients
Shuangmin Ji, Dewei Shang, Kehua Wu, et al.
Drug Design, Development and Therapy
|
April 22, 2025
Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches
Hui Xia, Guowei Deng, Fengtao Liang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 2, 2023
The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis
Zerui You, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Molecular Biosciences
|
December 3, 2021
Combining Metabolomics and Interpretable Machine Learning to Reveal Plasma Metabolic Profiling and Biological Correlates of Alcohol-Dependent Inpatients: What About Tryptophan Metabolism Regulation?
Xiuqing Zhu, Jiaxin Huang, Shanqing Huang, et al.
Journal of Ethnopharmacology
|
December 9, 2017
Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat
Jiajia Wang, Xiaofang Li, Shugui He, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Journal of Child and Adolescent Psychopharmacology
|
January 17, 2018
Comparison of Unlicensed and Off-Label Use of Antipsychotics Prescribed to Child and Adolescent Psychiatric Outpatients for Treatment of Mental and Behavioral Disorders with Different Guidelines: The China Food and Drug Administration Versus the FDA
Xiuqing Zhu, Jinqing Hu, Bin Sun, et al.
Drug Design, Development and Therapy
|
September 22, 2021
Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level
Shanqing Huang, Lu Li, Zhanzhang Wang, et al.
Therapeutic Drug Monitoring
|
December 13, 2024
Preliminary Determination of the Therapeutic Reference Range of Lurasidone in Chinese Patients and Analysis of the Factors Influencing Lurasidone Dose-Corrected Concentrations
Ye Yang, Zhanzhang Wang, Tao Xiao, et al.
Drug Design, Development and Therapy
|
August 11, 2021
What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly
Tao Xiao, Zhanzhang Wang, Guanlie Li, et al.
Human Psychopharmacology
|
November 20, 2023
Factors influencing concentrations of risperidone and 9-hydroxyrisperidone in psychiatric outpatients taking immediate-release formulations of risperidone
Zhihao Guo, Chunxiu Chen, Shuhua Deng, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
March 24, 2016
Population pharmacokinetic-pharmacodynamic (PopPK/PD) modeling of risperidone and its active metabolite in Chinese schizophrenia patients
Shuangmin Ji, Dewei Shang, Kehua Wu, et al.
Drug Design, Development and Therapy
|
April 22, 2025
Investigating Remedial Strategies for Missed or Delayed Dose of Sertraline in Chinese Adolescent Patients with Depressive Disorders via Population Pharmacokinetics Modeling and Simulation Approaches
Hui Xia, Guowei Deng, Fengtao Liang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
September 2, 2023
The contribution of polyamine pathway to determinations of diagnosis for treatment-resistant depression: A metabolomic analysis
Zerui You, Chengyu Wang, Xiaofeng Lan, et al.
Frontiers in Molecular Biosciences
|
December 3, 2021
Combining Metabolomics and Interpretable Machine Learning to Reveal Plasma Metabolic Profiling and Biological Correlates of Alcohol-Dependent Inpatients: What About Tryptophan Metabolism Regulation?
Xiuqing Zhu, Jiaxin Huang, Shanqing Huang, et al.
Journal of Ethnopharmacology
|
December 9, 2017
Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat
Jiajia Wang, Xiaofang Li, Shugui He, et al.
Page
of 6